Tang X L, Wang H X, Cho C H, Wong T M
Department of Physiology, Institute of Cardiovascular Science and Medicine, The University of Hong Kong, Hong Kong.
J Cardiovasc Pharmacol. 1998 Apr;31(4):493-8. doi: 10.1097/00005344-199804000-00004.
To determine the modulatory action of adenosine-receptor stimulation on [Ca2+]i responses to beta-adrenoceptor stimulation in the heart of the spontaneously hypertensive rat (SHR), the electrically induced [Ca2+]i transient in response to isoproterenol (ISO) in single ventricular myocytes pretreated with adenosine agonists in SHRs and its normotensive control Wistar-Kyoto (WKY) rats was measured with a spectrofluorometric method by using fura-2/AM as the calcium indicator. In both types of rat, ISO at 0.001-1 microM augmented the electrically induced [Ca2+]i transient, and the effect was blocked by a beta-adrenoceptor blocker, propranolol. In SHRs that did not exhibit cardiac hypertrophy, the resting level of [Ca2+]i and the amplitude of the electrically induced [Ca2+]i transient were the same as those in WKY rats, whereas the augmentation of the electrically induced [Ca2+]i transient in response to ISO was significantly lower than that in WKY rats. In WKY rats, the effects of ISO on the electrically induced [Ca2+]i transient were inhibited by the adenosine A1-receptor agonist, R(-)-N6-(2-phenylisopropyl)adenosine (R-PIA) at 0.01-10 microM. In contrast, the effects of ISO were further enhanced by the adenosine A2-receptor agonist, N6-[2-(3,5-dimethoxyphenyl)-2-(2-methylphenyl)-ethyl)]adenosine (DPMA) at 1-10 microM. In SHRs, the inhibitory effect of R-PIA was significantly reduced, whereas the excitatory effect of DPMA was absent. The effects of both adenosine-receptor agonists in both types of rat were abolished by the respective adenosine-receptor antagonists, 8-cyclopentyl-1,3-dipropylxanthine (DPCPX) and 3,7-dimethyl-1-propargylxanthine (DMPX). The results indicate that the modulatory actions of adenosine-receptor stimulation on [Ca2+]i response to beta-adrenoceptor stimulation in the hearts of SHRs are reduced, which is independent of cardiac hypertrophy.
为了确定腺苷受体刺激对自发性高血压大鼠(SHR)心脏中[Ca2+]i对β-肾上腺素能受体刺激反应的调节作用,采用荧光分光光度法,以fura-2/AM作为钙指示剂,测量了用腺苷激动剂预处理的SHR及其正常血压对照Wistar-Kyoto(WKY)大鼠单个心室肌细胞中对异丙肾上腺素(ISO)的电诱导[Ca2+]i瞬变。在两种类型的大鼠中,0.001-1 microM的ISO增强了电诱导的[Ca2+]i瞬变,且该效应被β-肾上腺素能受体阻滞剂普萘洛尔阻断。在未表现出心脏肥大的SHR中,[Ca2+]i的静息水平和电诱导的[Ca2+]i瞬变幅度与WKY大鼠相同,而对ISO的电诱导[Ca2+]i瞬变增强显著低于WKY大鼠。在WKY大鼠中,0.01-10 microM的腺苷A1受体激动剂R(-)-N6-(2-苯异丙基)腺苷(R-PIA)抑制了ISO对电诱导[Ca2+]i瞬变的作用。相反,1-10 microM的腺苷A2受体激动剂N6-[2-(3,5-二甲氧基苯基)-2-(2-甲基苯基)-乙基)]腺苷(DPMA)进一步增强了ISO的作用。在SHR中,R-PIA的抑制作用显著降低,而DPMA的兴奋作用不存在。两种类型大鼠中两种腺苷受体激动剂的作用均被各自的腺苷受体拮抗剂8-环戊基-1,3-二丙基黄嘌呤(DPCPX)和3,7-二甲基-1-丙炔基黄嘌呤(DMPX)消除。结果表明,腺苷受体刺激对SHR心脏中[Ca2+]i对β-肾上腺素能受体刺激反应的调节作用降低,这与心脏肥大无关。